journal of pharmaceutical sciences

european journal of hospital pharmacy : science and practice

[1] Magnetically Guided Self-Assembled Protein Micelles for Enhanced Delivery of Dasatinib to Human Triple-Negative Breast Cancer Cells.

[2] Challenges of Using Closed System Transfer Devices With Biological Drug Products: An Industry Perspective.

[3] emotional responses to persistent chemotherapy-induced peripheral neuropathy experienced by patients with colorectal cancer in japan

[4] a study of drug-drug interactions in cancer patients of a south indian tertiary care teaching hospital

[5] Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy

[6] Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy

[7] Temperature/pH-Triggered PNIPAM-Based Smart Nanogel System Loaded With Anastrozole Delivery for Application in Cancer Chemotherapy.

[8] Development of synthetic high-density lipoprotein-based ApoA-I mimetic peptide-loaded docetaxel as a drug delivery nanocarrier for breast cancer chemotherapy.

[9] Cyclic dipeptide nanoribbons formed by dye-mediated hydrophobic self-assembly for cancer chemotherapy.

[10] Numerical modeling of high-intensity focused ultrasound-mediated intraperitoneal delivery of thermosensitive liposomal doxorubicin for cancer chemotherapy

[11] GSH and enzyme responsive nanospheres based on self-assembly of green tea polyphenols and BSA used for target cancer chemotherapy

[12] Infection risk and cancer chemotherapy: the impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies.

[13] Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer

[14] Infection risk and cancer chemotherapy: the impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies

[15] is redox signaling a feasible target for overcoming multidrug resistance in cancer chemotherapy?

[16] cofactor: folate requirement for optimization of 5-fluouracil activity in anticancer chemotherapy

[17] pathobiology of cancer chemotherapy-induced peripheral neuropathy (cipn)

[18] goserelin, as an ovarian protector during (neo)adjuvant breast cancer chemotherapy, prevents long term altered bone turnover

[19] Hepatitis B Virus Reactivation in the Setting of Cancer Chemotherapy and Other Immunosuppressive Drug Therapy

[20] Precision Medicine and Cancer Chemotherapy